Review



dtcs  (ChemoMetec)


Bioz Verified Symbol ChemoMetec is a verified supplier
Bioz Manufacturer Symbol ChemoMetec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    ChemoMetec dtcs
    Design and functional evaluation of ATOR-4066. A, Structure of ATOR-4066 generated in the bispecific RUBY format. B, Mode of action of ATOR-4066, as proposed by Hägerbrand and colleagues . C, The ability of serially diluted ATOR-4066 to <t>induce</t> <t>CEACAM5</t> conditional activation of primary human MoDCs when cocultured for 48 hours with a sublethally UV-irradiated human CEACAM5-expressing cell line (MKN45) was assessed by measuring IL12 secretion in the supernatant by ELISA. Mean ± SD of normalized IL12 levels of nine donors was calculated, and EC 50 values were determined. D, The ability of ATOR-4066 to induce CEACAM5-conditional CD40 agonistic effects in a CD40 reporter assay was assessed in the presence of soluble CEACAM5 compared with a control CD40xCEACAM5 bsAb #3 with a high-affinity CEACAM5 binder targeting the same epitope as ATOR-4066, demonstrating that the CEACAM5 affinity is important. E, <t>DTCs,</t> including tumor-infiltrating CD40 + immune cells and CEACAM5 + tumor cells, obtained from patients with gastric cancer ( n = 6), were stimulated with ATOR-4066 in vitro for 72 hours, and activation markers, CD83 on myeloid cells and B cells, and CD25 on CD4 and CD8 T cells, were assessed using flow cytometry. F, Harvest titer of ATOR-4066 following production in 0.5 L and 1 L shaker flasks and in 2 L bioreactor. *, P ≤ 0.05; ns, not significant.
    Dtcs, supplied by ChemoMetec, used in various techniques. Bioz Stars score: 97/100, based on 642 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dtcs/pmc12670079-99-3-10?v=ChemoMetec
    Average 97 stars, based on 642 article reviews
    dtcs - by Bioz Stars, 2026-07
    97/100 stars

    Images

    1) Product Images from "ATOR-4066, a Bispecific Antibody Targeting CD40 and CEACAM5, Induces Strong Myeloid and T Cell–Dependent Tumor Immunity and Synergizes with PD-1 Blockade"

    Article Title: ATOR-4066, a Bispecific Antibody Targeting CD40 and CEACAM5, Induces Strong Myeloid and T Cell–Dependent Tumor Immunity and Synergizes with PD-1 Blockade

    Journal: Cancer Immunology Research

    doi: 10.1158/2326-6066.CIR-25-0075

    Design and functional evaluation of ATOR-4066. A, Structure of ATOR-4066 generated in the bispecific RUBY format. B, Mode of action of ATOR-4066, as proposed by Hägerbrand and colleagues . C, The ability of serially diluted ATOR-4066 to induce CEACAM5 conditional activation of primary human MoDCs when cocultured for 48 hours with a sublethally UV-irradiated human CEACAM5-expressing cell line (MKN45) was assessed by measuring IL12 secretion in the supernatant by ELISA. Mean ± SD of normalized IL12 levels of nine donors was calculated, and EC 50 values were determined. D, The ability of ATOR-4066 to induce CEACAM5-conditional CD40 agonistic effects in a CD40 reporter assay was assessed in the presence of soluble CEACAM5 compared with a control CD40xCEACAM5 bsAb #3 with a high-affinity CEACAM5 binder targeting the same epitope as ATOR-4066, demonstrating that the CEACAM5 affinity is important. E, DTCs, including tumor-infiltrating CD40 + immune cells and CEACAM5 + tumor cells, obtained from patients with gastric cancer ( n = 6), were stimulated with ATOR-4066 in vitro for 72 hours, and activation markers, CD83 on myeloid cells and B cells, and CD25 on CD4 and CD8 T cells, were assessed using flow cytometry. F, Harvest titer of ATOR-4066 following production in 0.5 L and 1 L shaker flasks and in 2 L bioreactor. *, P ≤ 0.05; ns, not significant.
    Figure Legend Snippet: Design and functional evaluation of ATOR-4066. A, Structure of ATOR-4066 generated in the bispecific RUBY format. B, Mode of action of ATOR-4066, as proposed by Hägerbrand and colleagues . C, The ability of serially diluted ATOR-4066 to induce CEACAM5 conditional activation of primary human MoDCs when cocultured for 48 hours with a sublethally UV-irradiated human CEACAM5-expressing cell line (MKN45) was assessed by measuring IL12 secretion in the supernatant by ELISA. Mean ± SD of normalized IL12 levels of nine donors was calculated, and EC 50 values were determined. D, The ability of ATOR-4066 to induce CEACAM5-conditional CD40 agonistic effects in a CD40 reporter assay was assessed in the presence of soluble CEACAM5 compared with a control CD40xCEACAM5 bsAb #3 with a high-affinity CEACAM5 binder targeting the same epitope as ATOR-4066, demonstrating that the CEACAM5 affinity is important. E, DTCs, including tumor-infiltrating CD40 + immune cells and CEACAM5 + tumor cells, obtained from patients with gastric cancer ( n = 6), were stimulated with ATOR-4066 in vitro for 72 hours, and activation markers, CD83 on myeloid cells and B cells, and CD25 on CD4 and CD8 T cells, were assessed using flow cytometry. F, Harvest titer of ATOR-4066 following production in 0.5 L and 1 L shaker flasks and in 2 L bioreactor. *, P ≤ 0.05; ns, not significant.

    Techniques Used: Functional Assay, Generated, Activation Assay, Irradiation, Expressing, Enzyme-linked Immunosorbent Assay, Reporter Assay, Control, In Vitro, Flow Cytometry



    Similar Products

    94
    MedChemExpress d tubocurarine chloride dtc
    D Tubocurarine Chloride Dtc, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dtcs/pmc12957844-72-2-25?v=MedChemExpress
    Average 94 stars, based on 1 article reviews
    d tubocurarine chloride dtc - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    86
    Clariant Inc product sandopan dtc
    Product Sandopan Dtc, supplied by Clariant Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dtcs/us12655365-396-8-5?v=Clariant+Inc
    Average 86 stars, based on 1 article reviews
    product sandopan dtc - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    86
    Eyela Co dtc 22 diaphragm pump
    Dtc 22 Diaphragm Pump, supplied by Eyela Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dtcs/10__1016_slash_j__afres__2026__102216-93-10-13?v=Eyela+Co
    Average 86 stars, based on 1 article reviews
    dtc 22 diaphragm pump - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    86
    Discovery Life Sciences Inc tumor cells dtcs
    Tumor Cells Dtcs, supplied by Discovery Life Sciences Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dtcs/us12618115-1363-37-40?v=Discovery+Life+Sciences+Inc
    Average 86 stars, based on 1 article reviews
    tumor cells dtcs - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    86
    Toshiba America Electronic Components Inc transmon coupler dtc
    Transmon Coupler Dtc, supplied by Toshiba America Electronic Components Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dtcs/arxiv__2601__11378-20-8-16?v=Toshiba+America+Electronic+Components+Inc
    Average 86 stars, based on 1 article reviews
    transmon coupler dtc - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    97
    ChemoMetec dtcs
    Design and functional evaluation of ATOR-4066. A, Structure of ATOR-4066 generated in the bispecific RUBY format. B, Mode of action of ATOR-4066, as proposed by Hägerbrand and colleagues . C, The ability of serially diluted ATOR-4066 to <t>induce</t> <t>CEACAM5</t> conditional activation of primary human MoDCs when cocultured for 48 hours with a sublethally UV-irradiated human CEACAM5-expressing cell line (MKN45) was assessed by measuring IL12 secretion in the supernatant by ELISA. Mean ± SD of normalized IL12 levels of nine donors was calculated, and EC 50 values were determined. D, The ability of ATOR-4066 to induce CEACAM5-conditional CD40 agonistic effects in a CD40 reporter assay was assessed in the presence of soluble CEACAM5 compared with a control CD40xCEACAM5 bsAb #3 with a high-affinity CEACAM5 binder targeting the same epitope as ATOR-4066, demonstrating that the CEACAM5 affinity is important. E, <t>DTCs,</t> including tumor-infiltrating CD40 + immune cells and CEACAM5 + tumor cells, obtained from patients with gastric cancer ( n = 6), were stimulated with ATOR-4066 in vitro for 72 hours, and activation markers, CD83 on myeloid cells and B cells, and CD25 on CD4 and CD8 T cells, were assessed using flow cytometry. F, Harvest titer of ATOR-4066 following production in 0.5 L and 1 L shaker flasks and in 2 L bioreactor. *, P ≤ 0.05; ns, not significant.
    Dtcs, supplied by ChemoMetec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dtcs/pmc12670079-99-3-10?v=ChemoMetec
    Average 97 stars, based on 1 article reviews
    dtcs - by Bioz Stars, 2026-07
    97/100 stars
      Buy from Supplier

    86
    Philips Healthcare siemens dtc
    Design and functional evaluation of ATOR-4066. A, Structure of ATOR-4066 generated in the bispecific RUBY format. B, Mode of action of ATOR-4066, as proposed by Hägerbrand and colleagues . C, The ability of serially diluted ATOR-4066 to <t>induce</t> <t>CEACAM5</t> conditional activation of primary human MoDCs when cocultured for 48 hours with a sublethally UV-irradiated human CEACAM5-expressing cell line (MKN45) was assessed by measuring IL12 secretion in the supernatant by ELISA. Mean ± SD of normalized IL12 levels of nine donors was calculated, and EC 50 values were determined. D, The ability of ATOR-4066 to induce CEACAM5-conditional CD40 agonistic effects in a CD40 reporter assay was assessed in the presence of soluble CEACAM5 compared with a control CD40xCEACAM5 bsAb #3 with a high-affinity CEACAM5 binder targeting the same epitope as ATOR-4066, demonstrating that the CEACAM5 affinity is important. E, <t>DTCs,</t> including tumor-infiltrating CD40 + immune cells and CEACAM5 + tumor cells, obtained from patients with gastric cancer ( n = 6), were stimulated with ATOR-4066 in vitro for 72 hours, and activation markers, CD83 on myeloid cells and B cells, and CD25 on CD4 and CD8 T cells, were assessed using flow cytometry. F, Harvest titer of ATOR-4066 following production in 0.5 L and 1 L shaker flasks and in 2 L bioreactor. *, P ≤ 0.05; ns, not significant.
    Siemens Dtc, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dtcs/pmc12777130-148-9-12?v=Philips+Healthcare
    Average 86 stars, based on 1 article reviews
    siemens dtc - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    90
    Technical Manufacturing Company peg-p (tmc-dtc)-spermine (ptd-sp)
    Design and functional evaluation of ATOR-4066. A, Structure of ATOR-4066 generated in the bispecific RUBY format. B, Mode of action of ATOR-4066, as proposed by Hägerbrand and colleagues . C, The ability of serially diluted ATOR-4066 to <t>induce</t> <t>CEACAM5</t> conditional activation of primary human MoDCs when cocultured for 48 hours with a sublethally UV-irradiated human CEACAM5-expressing cell line (MKN45) was assessed by measuring IL12 secretion in the supernatant by ELISA. Mean ± SD of normalized IL12 levels of nine donors was calculated, and EC 50 values were determined. D, The ability of ATOR-4066 to induce CEACAM5-conditional CD40 agonistic effects in a CD40 reporter assay was assessed in the presence of soluble CEACAM5 compared with a control CD40xCEACAM5 bsAb #3 with a high-affinity CEACAM5 binder targeting the same epitope as ATOR-4066, demonstrating that the CEACAM5 affinity is important. E, <t>DTCs,</t> including tumor-infiltrating CD40 + immune cells and CEACAM5 + tumor cells, obtained from patients with gastric cancer ( n = 6), were stimulated with ATOR-4066 in vitro for 72 hours, and activation markers, CD83 on myeloid cells and B cells, and CD25 on CD4 and CD8 T cells, were assessed using flow cytometry. F, Harvest titer of ATOR-4066 following production in 0.5 L and 1 L shaker flasks and in 2 L bioreactor. *, P ≤ 0.05; ns, not significant.
    Peg P (Tmc Dtc) Spermine (Ptd Sp), supplied by Technical Manufacturing Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dtcs/pmc12272602-223-17-18?v=Technical+Manufacturing+Company
    Average 90 stars, based on 1 article reviews
    peg-p (tmc-dtc)-spermine (ptd-sp) - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    Image Search Results


    Design and functional evaluation of ATOR-4066. A, Structure of ATOR-4066 generated in the bispecific RUBY format. B, Mode of action of ATOR-4066, as proposed by Hägerbrand and colleagues . C, The ability of serially diluted ATOR-4066 to induce CEACAM5 conditional activation of primary human MoDCs when cocultured for 48 hours with a sublethally UV-irradiated human CEACAM5-expressing cell line (MKN45) was assessed by measuring IL12 secretion in the supernatant by ELISA. Mean ± SD of normalized IL12 levels of nine donors was calculated, and EC 50 values were determined. D, The ability of ATOR-4066 to induce CEACAM5-conditional CD40 agonistic effects in a CD40 reporter assay was assessed in the presence of soluble CEACAM5 compared with a control CD40xCEACAM5 bsAb #3 with a high-affinity CEACAM5 binder targeting the same epitope as ATOR-4066, demonstrating that the CEACAM5 affinity is important. E, DTCs, including tumor-infiltrating CD40 + immune cells and CEACAM5 + tumor cells, obtained from patients with gastric cancer ( n = 6), were stimulated with ATOR-4066 in vitro for 72 hours, and activation markers, CD83 on myeloid cells and B cells, and CD25 on CD4 and CD8 T cells, were assessed using flow cytometry. F, Harvest titer of ATOR-4066 following production in 0.5 L and 1 L shaker flasks and in 2 L bioreactor. *, P ≤ 0.05; ns, not significant.

    Journal: Cancer Immunology Research

    Article Title: ATOR-4066, a Bispecific Antibody Targeting CD40 and CEACAM5, Induces Strong Myeloid and T Cell–Dependent Tumor Immunity and Synergizes with PD-1 Blockade

    doi: 10.1158/2326-6066.CIR-25-0075

    Figure Lengend Snippet: Design and functional evaluation of ATOR-4066. A, Structure of ATOR-4066 generated in the bispecific RUBY format. B, Mode of action of ATOR-4066, as proposed by Hägerbrand and colleagues . C, The ability of serially diluted ATOR-4066 to induce CEACAM5 conditional activation of primary human MoDCs when cocultured for 48 hours with a sublethally UV-irradiated human CEACAM5-expressing cell line (MKN45) was assessed by measuring IL12 secretion in the supernatant by ELISA. Mean ± SD of normalized IL12 levels of nine donors was calculated, and EC 50 values were determined. D, The ability of ATOR-4066 to induce CEACAM5-conditional CD40 agonistic effects in a CD40 reporter assay was assessed in the presence of soluble CEACAM5 compared with a control CD40xCEACAM5 bsAb #3 with a high-affinity CEACAM5 binder targeting the same epitope as ATOR-4066, demonstrating that the CEACAM5 affinity is important. E, DTCs, including tumor-infiltrating CD40 + immune cells and CEACAM5 + tumor cells, obtained from patients with gastric cancer ( n = 6), were stimulated with ATOR-4066 in vitro for 72 hours, and activation markers, CD83 on myeloid cells and B cells, and CD25 on CD4 and CD8 T cells, were assessed using flow cytometry. F, Harvest titer of ATOR-4066 following production in 0.5 L and 1 L shaker flasks and in 2 L bioreactor. *, P ≤ 0.05; ns, not significant.

    Article Snippet: Directly after thawing, DTCs were counted using a NucleoCounter NC-200 (ChemoMetec), stained for CEACAM5 and CD40, and analyzed by flow cytometry to confirm target expression at baseline.

    Techniques: Functional Assay, Generated, Activation Assay, Irradiation, Expressing, Enzyme-linked Immunosorbent Assay, Reporter Assay, Control, In Vitro, Flow Cytometry